Longevity Vision Fund
22
123M
15
4.40
1
0.32
3
- Areas of investment
Summary
The main office of represented VC is situated in the New York. The company was established in North America in United States.
The important activity for fund was in 2019. Deals in the range of 50 - 100 millions dollars are the general things for fund. When the investment is from Longevity Vision Fund the average startup value is 100-500 millions dollars. The fund is generally included in 2-6 deals every year.
We can highlight the next thriving fund investment areas, such as Medical, Clinical Trials. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight LyGenesis. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 8-9 partakers. Despite the Longevity Vision Fund, startups are often financed by Founders Fund, Data Collective DCVC, Bold Capital Partners. The meaningful sponsors for the fund in investment in the same round are Bold Capital Partners, Wanxiang Healthcare Investments, Verily.
Investments analytics
Analytics
- Total investments
- 22
- Lead investments
- 1
- Exits
- 3
- Rounds per year
- 4.40
- Follow on index
- 0.32
- Investments by industry
- Biotechnology (19)
- Health Care (11)
- Medical (7)
- Biopharma (5)
- Therapeutics (4) Show 12 more
- Investments by region
-
- United States (18)
- China (3)
- Peak activity year
- 2019
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 120M
- Group Appearance index
- 1.00
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Freelawyer | 01 Jun 2013 | Internet, Legal | Seed | ||
| Insilico Medicine | 09 Sep 2019 | Biotechnology, Artificial Intelligence, Health Care, Genetics, Pharmaceutical | Early Stage Venture | 37M | Hong Kong Island, Hong Kong, China |
| QuickInsured | 23 Jul 2018 | Insurance, Life Insurance | Seed | United States, Ohio, Columbus | |
| Senda Biosciences | 10 Jun 2021 | Biotechnology, Life Science | Early Stage Venture | 98M | United States, Massachusetts, Cambridge |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.